2015 annual financial data
Alnylam Pharmaceuticals 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -460.23%.
Operating income was -296,008,000 USD and net income was -290,073,000 USD.
Operating cash flow was -189,140,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41,097,000 USD
- Operating income
- -296,008,000 USD
- Net income
- -290,073,000 USD
- Operating cash flow
- -189,140,000 USD